Rupee Ends Lower Snapping Five-Day Winning Streak
The rupee closed lower on Tuesday, snapping a five-day winning streak, as rising crude oil prices and a recovery in the dollar index weighed on sentiment.
The local unit settled at 85.20 against the US dollar, down 7 paise from its previous close of 85.13. Earlier in the day, it had opened flat at the same level.
Brent crude gained 1.60% to $67.32 per barrel, while the dollar index rose 0.08% to 98.36. Analysts attributed the rupee's weakness to profit booking, rising oil prices, and dollar short covering.
“On the domestic front, the rupee faced pressure from RBI's dollar purchases via state-run banks. However, optimism remains for Indian assets, supported by falling bond yields and strong foreign inflows,” said Amit Pabari, managing director at CR Forex Advisors. “With Indian equities up over 1.1% and Rs 4,000 crore of foreign fund inflows, the sentiment remains positive.”
Pabari expects the rupee to trade in a narrow band of 85.00 to 85.40 in the near term. “The 10-year bond yield has dropped to 6.317%, the lowest since December 2021, driven by expectations of further rate cuts and the RBI's supportive stance,” he said.
Globally, investors remained cautious after US President Donald Trump warned of an economic slowdown unless the US Federal Reserve cuts interest rates. “These comments, along with dovish Fed statements, pushed the dollar index to a low of 97.92—its weakest since April 2022,” said Pabari.
Mounting political pressure ahead of a massive $9.2 trillion debt refinancing could continue to influence Fed policy, he added. “A rate cut would ease short-term borrowing costs, though it could risk stoking inflation. Dollar index may find strong support at 98.00, while resistance lies at 99.50. A breakout could push it towards 101.50-102.00.”
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.